title: [Lethal midline granuloma (LMG)].
authors.affiliation: Kliniki Chemioterapii Oddziału Krakowskiego Centrum Onkologii Instytutu im M. Skłodowskiej-Curie.
authors.forename: J
authors.initials: J
authors.lastname: Rolski
authors.forename: K
authors.initials: K
authors.lastname: Smolak
authors.forename: A
authors.initials: A
authors.lastname: Gruchała
authors.forename: R
authors.initials: R
authors.lastname: Drazek
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006103:Granuloma, Lethal Midline / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D009302:Nasopharyngeal Diseases / Q000175:diagnosis* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Lethal midline granuloma (LMG).